Webinar: Navigating the Saudi Market: Insights into Incentives and New Regulatory Frameworks
Event Date : 22-Jun-2025
In partnership with TOPRA, we’re excited to present an exclusive session by Pi Pharma Intelligence and HEPA Digital, focusing on critical topics shaping market access and regulatory developments in Saudi Arabia.
This session highlights the opportunities available for companies entering the Saudi market and offers guidance on aligning with its specific requirements. Key topics covered include:
- Latest Incentives for Accessing the Saudi Market.
- This session will provide valuable insights into the latest government initiatives and incentives designed to facilitate market access in Saudi Arabia. Learn about the opportunities and the strategies that can help pharmaceutical companies successfully enter and expand in the Saudi market.
- New Regulations Regarding Economic Evaluation Studies in the Saudi Market.
- Stay informed about the new regulations governing economic evaluation studies in Saudi Arabia. Our experts will guide you through the latest requirements and how these regulations influence market entry, product evaluation, and development strategies in the country.
Don’t miss out on this exclusive session, request the slides and session video
IA y propiedad intelectual: surcando nuevas fronteras para la farmacia española en MENA
Aug, 2024
Profundiza en la integración transformadora de la inteligencia artificial (IA) y la propiedad intelectual (PI) dentro del sector farmacéutico español, destacando las oportunidades sin precedentes que ofrece la región MENA.
Revolutionizing Patient Access: The Role of Pi Pharma Intelligence in Shaping Healthcare Solutions in MENA
Mar, 2024
Pi Pharma Intelligence is at the forefront of revolutionizing patient access to healthcare solutions in the MENA region, offering Spanish pharmaceutical companies unparalleled insights to overcome access barriers.
The Impact of Healthcare Policy Changes on Pharmaceutical Strategies in Emerging Markets
Mar, 2024
Uncover how these policy shifts impact market access, pricing, and distribution, influencing pharmaceutical companies' strategic decisions.